|
Jun 24
|
Did Seagen Acquisition Help Pfizer Inc. (PFE) Increase Revenue in Q1?
|
|
Jun 24
|
2 Beaten-Down Growth Stocks to Buy Without Hesitation in the 2024 Bull Market
|
|
Jun 24
|
Alnylam says heart drug succeeds in closely watched study
|
|
Jun 23
|
Want an Extra $100 in Annual Dividend Income? Invest $1,320 in These 3 High-Yield Stocks
|
|
Jun 22
|
The Most Populated Country in the World
|
|
Jun 22
|
3 No-Brainer Stocks to Buy for Under $100 Right Now
|
|
Jun 22
|
3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold
|
|
Jun 21
|
Sarepta Catapults 30% After Hitting A 'Grand Slam' Approval In Muscular Dystrophy
|
|
Jun 21
|
Sarepta’s Elevidys secures US label expansion for DMD
|
|
Jun 21
|
FDA Expands Sarepta's (SRPT) DMD Gene Therapy Label
|
|
Jun 21
|
Sarepta Stock Surges on Expanded Elevidys Approval. It’s a ‘Best-Case’ Scenario for Shares.
|
|
Jun 21
|
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
|
|
Jun 21
|
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
|
|
Jun 20
|
Why Wall Street Is Chasing Ozempic Wannabes
|
|
Jun 20
|
Sarepta Duchenne gene therapy wins broader use from FDA
|
|
Jun 18
|
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider
|
|
Jun 18
|
Merck Prepares to Take on Pfizer After Pneumococcal Vaccine Approval
|
|
Feb 4
|
20 States with the Oldest Population in the US
|
|
Feb 4
|
3 Fabulous Dividend Stocks to Buy in February
|
|
Feb 2
|
Bristol-Myers (BMY) Q4 Earnings & Sales Beat, Stock Gains
|